Xcout Intel
Colossal Biosciences Inc. competitors & alternatives
The 12 closest competitors and alternatives to Colossal Biosciences Inc. among biotechnology companies — ranked by similarity to what Colossal Biosciences Inc. actually does, not by market-cap band.
Subscribe to see Colossal Biosciences Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Colossal Biosciences Inc.
Colossal Biosciences is a biotechnology and genetic science company headquartered in Dallas, Texas, specializing in de-extinction initiatives and advanced genomics research.
Colossal Biosciences Inc. at a glance
Colossal Biosciences Inc. is a biotechnology company headquartered in United States. Its most recent funding round, Series C, raised $200M in January 2025. Xcout tracks 3 named people at Colossal Biosciences Inc., including Beth Shapiro (Chief Science Officer). Xcout recorded 21 job postings from Colossal Biosciences Inc. in the last 90 days.
Colossal Biosciences Inc. leadership
- Beth ShapiroChief Science Officer
- Ben LammCo-Founder and CEO
- George ChurchCo-founder and lead genetics advisor
Colossal Biosciences Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series C | $200M | — | |
| Series C | $10.5M | — | |
| SEC Form D filing | $162.6M | — | |
| Series C | $162.6M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Colossal Biosciences Inc.
Xcout recorded 21 job postings from Colossal Biosciences Inc. in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Colossal Biosciences Inc.'s hiring signals →
Recent Colossal Biosciences Inc. news
- FundingPrivate placement (Form D)
Top 12 Colossal Biosciences Inc. competitors
Ranked by semantic similarity — how close each company is to Colossal Biosciences Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Mammoth Biosciences is a biotechnology company based in Brisbane, California developing diagnostic tests using CRISPR-Cas12a and CRISPR-based therapies using its proprietary ultra-small CRISPR systems. Several CRISPR-Cas systems identified through the company's metagenomics-based protein discovery platform, including members of the Casφ and Cas14 families of CRISPR-associated enzymes, have demonstrated potential for therapeutic genome editing in in vivo settings.
Similar biotechnology company
Exsilio Therapeutics Inc. is a biotechnology company headquartered in Boston, Massachusetts, founded in 2022 to pioneer genomic medicines and advanced genetic therapies.
Similar biotechnology company
KOMO Biosciences is a biotechnology research company headquartered in Cambridge, Massachusetts. The company specializes in next-generation precision genome engineering driven by highly efficient, evolved integrases.
Similar biotechnology company
Code Biotherapeutics, Inc. is a biotechnology company headquartered in the Greater Philadelphia area. The firm focuses on next-generation gene therapies and advanced medicine.
Similar biotechnology company
Prime Medicine, Inc. is an American biotechnology company developing gene therapies based on prime editing. The company is headquartered in Cambridge, Massachusetts.
Life Science
Synthorx, Inc., founded in 2014, is a biotechnology company headquartered in La Jolla, California, that engineered expanded genetic alphabet technologies to discover and develop novel protein therapeutics.
Similar biotechnology company
Verve Therapeutics, Inc. is a biotechnology company headquartered in Boston, Massachusetts, dedicated to pioneering single-course gene editing medicines for cardiovascular disease.
Similar biotechnology company
Epicrispr Biotechnologies is a pioneering therapeutics company dedicated to developing advanced genetic medicines. The organization focuses on scientific research, platforms, and clinical pipelines to treat serious diseases.
Biotech
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Biotech
Deep Genomics is a biotechnology research company that collaborates across disciplines to solve complex molecular design challenges. The company's corporate headquarters are located in Toronto, Ontario, Canada, a hub for innovation.
Similar biotechnology company
Excision BioTherapeutics Inc. is a San Francisco-based clinical-stage biotechnology company focused on developing advanced gene editing therapeutics to treat infectious diseases.
Similar biotechnology company
Dyne Therapeutics, Inc. is a U.S.-based biotechnology firm focused on developing advanced treatments for genetically driven muscle disorders. Utilizing its proprietary FORCE platform, which is engineered to deliver disease-modifying therapeutics, the company is actively engaged in various programs. These initiatives target conditions such as myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral dystrophy, in addition to other rare skeletal, cardiac, and metabolic muscle diseases. The company was founded in 2017 and maintains its corporate headquarters in Waltham, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Colossal Biosciences Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Colossal Biosciences Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →